+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Complex of iron hydroxide with polymaltose Efficacy in cases on infantile iron deficiency



Complex of iron hydroxide with polymaltose Efficacy in cases on infantile iron deficiency



Pediatriya (Moscow) (6): 67-72




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034627740

Download citation: RISBibTeXText


Related references

A comparative study of iron salts vs hydroxide polymaltose iron complex efficacy in the treatment of iron deficiency anemia in presenile and senile patients. Gematologiya i Transfuziologiya 49(1): 29-32, 2004

Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children. International Journal of Clinical Pharmacology and Therapeutics 36(6): 320-325, 1998

Effect of oral aluminium hydroxide on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study. Arzneimittel-Forschung 57(6a): 392-400, 2007

Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia. International Journal of Pediatrics 2011: 524520, 2011

Effect of oral tetracycline on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study. Arzneimittel-Forschung 57(6a): 376-384, 2007

Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis. Arzneimittel-Forschung 57(6a): 431-438, 2007

Effect of an oral iron(III)-hydroxide polymaltose complex on tetracycline pharmacokinetics in patients with iron deficiency anemia. Arzneimittel-Forschung 57(6a): 385-391, 2007

Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy. Journal of the Association of Physicians of India 50: 279-280, 2002

Effect of treatment with single total-dose intravenous iron versus daily oral iron(III)-hydroxide polymaltose on moderate puerperal iron-deficiency anemia. Therapeutics and Clinical Risk Management 13: 647-653, 2017

Comparative evaluation of efficacy and tolerance of iron polymaltose complex and ferrous sulphate for treatment of iron deficiency anemia in infants. Revista de la Facultad de Ciencias Medicas 69(2): 97-101, 2012

Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women. Medgenmed 9(1): 1, 2007

Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience. Arzneimittel-Forschung 57(6a): 439-452, 2007

Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia. Hematology 12(3): 255-256, 2007

Iron hydroxide polymaltose--cause of persistent iron deficiency anemia at delivery. Indian Journal of Medical Sciences 55(11): 616-620, 2001

Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study. Journal of Maternal-Fetal and Neonatal Medicine 24(11): 1347-1352, 2011